|
DTWD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62492241884138E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.55431223447522E-15 |
| Normal-vs-Stage2 |
2.282000E-03 |
| Normal-vs-Stage3 |
1.45439216225896E-14 |
| Normal-vs-Stage4 |
1.11022302462516E-16 |
| Stage1-vs-Stage2 |
5.829600E-04 |
| Stage1-vs-Stage3 |
1.158390E-01 |
| Stage1-vs-Stage4 |
1.240440E-04 |
| Stage2-vs-Stage3 |
9.53900000000285E-05 |
| Stage2-vs-Stage4 |
6.61620000008689E-07 |
| Stage3-vs-Stage4 |
4.976300E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.03029999995752E-06 |
| Normal-vs-Asian |
6.81965595106249E-12 |
| Caucasian-vs-AfricanAmerican |
8.558200E-01 |
| Caucasian-vs-Asian |
3.668000E-01 |
| AfricanAmerican-vs-Asian |
5.243400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.64646074551911E-13 |
| Normal-vs-Female |
1.62614366416847E-12 |
| Male-vs-Female |
4.565000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.64512847788956E-12 |
| Normal-vs-Age(41-60Yrs) |
3.99680288865056E-15 |
| Normal-vs-Age(61-80Yrs) |
1.46669998368765E-09 |
| Normal-vs-Age(81-100Yrs) |
4.760900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.442600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.414400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.718800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.833610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.807200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.616200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.17729999999672E-05 |
| Classical-VS-Follicular |
2.08669999999245E-05 |
| Classical-VS-Other |
6.257200E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
1.45280010244164E-10 |
| Tall-VS-Other |
3.626800E-01 |
| Tall-VS-Normal |
1.62458935193399E-12 |
| Follicular-VS-Other |
8.196000E-02 |
| Follicular-VS-Normal |
7.180300E-04 |
| Other-VS-Normal |
4.574900E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.66770042220321E-10 |
| Normal-vs-N1 |
1.62747593179802E-12 |
| N0-vs-N1 |
1.635440E-04 |
|
|
